The link between ORAI1 and the PI3K/AKT pathway in chemotherapeutic agent resistance has also been reported in a hepatocellular carcinoma cell line (HepG2) exposed to 5-FU [52]. The gene discussed is ORAI1; the disease is hepatocellular carcinoma.